Testing effectiveness (Phase 2)Study completedNCT02227693
What this trial is testing
Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
Who this might be right for
Thrombocytopenia Associated With Chronic Liver Disease
Eisai Co., Ltd. 39